Last update:

Oncology & Cancer news

Oncology & Cancer

AI detects the stiffness of cancer cell exosomes, enhancing lung cancer diagnostic accuracy

A research team has developed a technology that distinguishes lung cancer gene mutations solely by measuring the "stiffness" of exosomes—tiny particles released from cancer cells in the bloodstream—using atomic force ...

Oncology & Cancer

Study finds cancer cells boost energy to survive mechanical stress and DNA damage

Cancer cells mount an instant, energy‑rich response to being physically squeezed, according to a study published in the journal Nature Communications. The surge of energy is the first reported instance of a defensive mechanism ...

Oncology & Cancer

Unmutated tumor antigens: Exploitable targets for immunotherapy

A team headed by Claude Perreault, Director of IRIC's Immunobiology Research Unit and Professor at the Faculty of Medicine at Université de Montréal, has identified novel tumor antigens that could lead to the development ...

Oncology & Cancer

Colon cancer and exercise: Can physical activity reprogram genes?

A new study led by researchers at Huntsman Cancer Institute at the University of Utah (the U) shows that regular exercise may do more than help colon cancer patients feel better—it may actually change gene activity in both ...

Oncology & Cancer

Powering up T cells: A new path in cancer immunotherapy

Researchers have discovered a way to make the immune system's T cells significantly more effective at fighting cancer. By blocking a protein called Ant2, they were able to reprogram how these cells consume and generate energy—essentially ...

Oncology & Cancer

Study offers clearer picture of childhood brain tumor survival

Childhood brain tumor survival depends on the type of tumor. Comparing survival rates across countries is difficult, because brain tumors aren't recorded in the same way everywhere in Europe. A new study led by the Princess ...

Oncology & Cancer

Researcher uses light to target and kill cancer cells

A Northeastern University researcher has identified a way to target two of the deadliest cancer types, melanoma and triple negative breast cancer, with chemotherapy drugs but without the harms associated with chemotherapy.

Medical research

New cyclic disulfide lipids help stop cancer growth in mice

Researchers at Nagoya University in Japan have developed a lipid nanoparticle that delivers mRNA to cells five times more effectively. By attaching a sulfur-containing ring structure—a cyclic disulfide—to lipid molecules, ...

Oncology & Cancer

Prostate cancer explained: From antigen tests to treatment options

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos Vargas, a Mayo Clinic radiation ...

Oncology & Cancer

Lung cancer screening lags behind breast and colorectal screenings

Lung cancer screening has the potential to catch lung cancer early and save lives—but only if people get screened. Although lung cancer screening is recommended in the U.S. for certain individuals with a history of smoking, ...

Oncology & Cancer

Combination approach to advanced cancer could improve survival

An international team of researchers, including experts from the University of Adelaide, has found genomic testing and targeted therapies for patients with advanced cancer could improve survival rates by up to 40%.

Medical research

Nanoparticles extend glioblastoma survival in phase one trial

Despite decades of research to develop effective treatments, the median survival for glioblastoma—the most common malignant primary brain tumor in adults—is just 15–18 months after diagnosis. One reason for this grim ...

Oncology & Cancer

Advancements in ctDNA detection promise improved lymphoma outcomes

A research team led by Prof. Gu Hongcang from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has published a comprehensive systematic review on circulating tumor DNA (ctDNA) technologies and their ...

Oncology & Cancer

SOX9 as a prognostic marker in gastric adenocarcinoma

Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide, with more than one million new diagnoses annually. Unfortunately, many cases are detected at advanced stages due to the lack of clear early symptoms, ...

Oncology & Cancer

Faster cancer diagnostics with new laser-based method

Researchers from the Faculty of Physics and the Life Sciences Center of Vilnius University (VU), with co-authors from Harvard University, the University of Toronto, National Cancer Institute and "Light Conversion," have developed ...